Why Did None of My Embryos Make It to Blastocyst?

Total embryo arrest, where every embryo in an IVF cycle stops developing before reaching the blastocyst stage, affects a meaningful share of patients and almost always results from multiple factors converging at once. Roughly 40 percent of people undergoing IVF experience some degree of early embryonic arrest, and for a subset of those patients, none of the embryos survive to day five or six. The causes range from chromosomal errors during the embryo’s first cell divisions to egg quality, sperm DNA damage, and even subtle lab conditions. Understanding what went wrong is the first step toward figuring out whether a second attempt is likely to go differently.

How Often Embryos Fail to Reach Blastocyst

Not every fertilized egg is destined to become a blastocyst, even under ideal circumstances. In one widely cited study, only about 39 percent of all embryos reached the blastocyst stage by day five. Among embryos graded as good quality on day three, the rate climbed to 47 percent, while poor-quality day-three embryos had a blastocyst rate of just 21 percent.¹ Those numbers mean that in a cycle producing, say, four or five embryos, losing all of them before blastocyst is uncommon but far from unheard of, especially when embryo quality is marginal to begin with.

The reason so many embryos stall has to do with a series of biological hurdles that occur between fertilization and day five. Each hurdle requires different cellular machinery, and any one failure can halt development entirely. When a patient loses every embryo, it usually means one or more of these hurdles was insurmountable for that particular batch of eggs and sperm under those specific conditions.

The Genome Handoff

One of the least understood but most consequential events in early embryo development is something researchers call the maternal-to-zygotic transition. For the first couple of days after fertilization, the embryo runs almost entirely on molecular instructions stored in the egg. Around the eight-cell stage in humans, the embryo’s own genome has to switch on and take over. If it fails to do so, the embryo stalls.

Research using single-cell molecular profiling has shown that embryos which arrest at the cleavage stage often fail to activate their genomes or undergo the necessary reprogramming of their gene-expression patterns. The study authors concluded that failure at this step has implications for IVF outcomes comparable to those of chromosomal abnormalities.² More recent work has pinpointed specific genes whose activation appears critical at this transition; when those genes fail to turn on properly, cleavage-stage arrest follows.³

What makes this especially tricky is that the transition depends on both what the egg brought to the table and how the embryo’s new genome responds. Arrested embryos have been found to enter a kind of senescent-like state marked by metabolic problems, including disrupted energy production pathways.⁴ In plain terms, the embryo runs out of instructions, cannot generate its own, and essentially shuts down. This is not something that can be seen under a microscope on day two or three, which is one reason total arrest can come as such a surprise.

Chromosomal Errors in the First Cell Divisions

Chromosome problems are probably the single most studied cause of embryo arrest. When researchers genetically analyze embryos that stop developing, about 90 percent carry chromosomal abnormalities.⁵ But the picture is more nuanced than “the egg or sperm had the wrong number of chromosomes.”

Some chromosomal errors originate during the formation of the egg or sperm (meiotic errors). These are the classic age-related errors most people hear about. But a growing body of evidence suggests that errors arising during the embryo’s own early cell divisions, called mitotic errors, are actually a bigger driver of arrest. In one large analysis, embryos with only meiotic errors arrested about 36 percent of the time, while embryos with mitotic errors arrested at rates between 55 and 64 percent. By comparison, chromosomally normal embryos arrested only 16 percent of the time.⁶ The more chromosomes that were affected, the higher the chances of arrest. Embryos with complex abnormalities involving many chromosomes at once almost never survived.

Other research has confirmed that post-meiotic abnormalities such as polyploidy (having extra complete sets of chromosomes) and mosaicism (where different cells in the same embryo have different chromosome counts) become more frequent as embryos develop more slowly or arrest earlier.⁷ These mitotic errors likely stem from problems with the spindle machinery that separates chromosomes during cell division, or from issues with the mitochondria supplying energy to the process.⁵

Egg Quality and Maternal Age

Age is the factor most patients already suspect, and the science backs up that intuition to a degree. As women age, oocyte quality declines in ways that go beyond just a higher rate of chromosomal errors during meiosis. The mitochondria inside eggs, which supply the energy for all those early cell divisions, become less efficient. Research in animal models has shown that advanced maternal age is closely tied to impaired mitochondrial function and increased susceptibility to a form of cell death driven by iron-dependent damage to cell membranes.⁸

That said, age alone does not explain every case of total embryo arrest. Younger patients with otherwise unexplained infertility can experience it too, particularly when genetic or metabolic factors are at play. Age amplifies many of the other risks on this list, from chromosomal errors to poor genome activation, but it is rarely the sole culprit.

Sperm DNA Fragmentation

For a long time, sperm contribution was dismissed as a minor factor because fertilization could still occur even with damaged sperm, especially with ICSI. But fertilization is not the whole story. Sperm DNA fragmentation, where breaks accumulate in the DNA strands inside sperm, tends to exert what researchers describe as a “late paternal effect.” The embryo may look normal in the first couple of days, forming pronuclei and beginning to divide, but then stalls around the time the paternal genome is supposed to become active.⁹

Studies looking directly at blastocyst formation have found a clear negative relationship between sperm DNA fragmentation levels and blastulation rates, even though fertilization rates stayed the same. High DNA damage in sperm promoted embryo arrest and triggered cell-death pathways in the developing embryo.¹⁰ This is a frustrating finding for patients because standard semen analysis (count, motility, morphology) does not capture DNA fragmentation. A separate test is needed, and it is not always ordered as part of initial workup. If all your embryos arrested after apparently normal fertilization, sperm DNA fragmentation is worth investigating.

What Happens in the Lab

The culture environment inside the IVF lab is not a neutral backdrop. Embryos develop in incubators where temperature, gas mixture, humidity, and culture media are all tightly controlled, and small variations can shift outcomes. One variable that has received increasing attention is oxygen concentration. Inside the human body, embryos develop in relatively low-oxygen conditions. Many IVF labs have moved from culturing embryos in atmospheric oxygen (about 20 percent) to reduced oxygen (around 5 percent), and some research suggests going even lower could help.

A study of low-quality cleavage-stage embryos found that culturing them at 2 percent oxygen produced a significantly higher blastulation rate compared to 5 percent oxygen, roughly 40 percent versus 31 percent.¹¹ Animal studies have confirmed the same pattern: embryos cultured under lower oxygen conditions reached blastocyst at substantially higher rates than those in higher oxygen.¹² This does not mean your lab did anything wrong. Most clinics already use reduced oxygen, and even within reduced-oxygen systems, some embryos still will not make it. But if your clinic was using atmospheric oxygen, it is a question worth asking.

Other lab variables, including the specific culture media brand, the timing of media changes, and whether a time-lapse incubator was used (which avoids repeatedly removing embryos from the incubator for inspection), can have marginal effects. None of these alone would typically cause total arrest, but they contribute to the overall environment that either supports or stresses developing embryos.

Genetic Mutations That Cause Repeated Arrest

For a small but significant number of patients, repeated total embryo arrest across multiple IVF cycles points toward an inherited genetic cause. Researchers have identified mutations in a growing list of genes that are essential for early embryo development. These include genes involved in forming the subcortical maternal complex (a structure inside the egg that helps coordinate early cell divisions) and genes that regulate the maternal-to-zygotic transition discussed earlier. Specific genes implicated include NLRP5, PADI6, TUBB8, PATL2, and others, with PATL2 mutations specifically hypothesized to disrupt the genome handoff step.¹³

On the paternal side, mutations in genes like CFAP69, ACTL7A, and M1AP interfere with sperm development in ways that go beyond what a standard semen analysis can detect.¹³ Animal studies have underscored just how critical some of these maternal-effect genes are. Mice lacking the gene Zar1, for example, are otherwise completely normal but totally infertile: their embryos arrest at the one-cell stage, and not a single embryo reaches the four-cell stage.¹⁴

Genetic testing for these mutations is not yet part of standard IVF workup at most clinics, but it is increasingly available at specialized centers. If you have experienced total arrest more than once, particularly if embryos consistently stop at the same stage, asking about genetic panel testing for early embryonic arrest genes is reasonable.

Does Changing the Stimulation Protocol Help?

One of the first things a reproductive endocrinologist will consider after a cycle with total arrest is whether to change the ovarian stimulation protocol. The logic is intuitive: maybe a different hormonal approach would produce better-quality eggs. Studies comparing different stimulation regimens have found differences in the total number of good-quality blastocysts produced, with more aggressive protocols yielding more blastocysts in absolute terms, but the rate at which embryos become top-quality blastocysts has not consistently differed between protocols.¹⁵ Similarly, research on the relationship between stimulation drug doses and blastocyst chromosome normalcy has found no significant link.¹⁶

A recent matched analysis of patients who experienced complete embryo developmental arrest looked specifically at whether switching the stimulation protocol or trigger type improved outcomes in the next cycle. The answer was discouraging: changing protocols did not significantly improve blastulation rates or reduce the risk of another total failure compared to keeping the same protocol.¹⁷ This suggests that for many patients, the limiting factor is not the stimulation itself but the underlying egg, sperm, or embryo biology. Protocol changes may still be tried, and individual circumstances vary, but patients should not assume a protocol switch alone will solve the problem.

Lab Interventions and Oocyte Activation

When fertilization failure or very early arrest is suspected to involve problems with egg activation after sperm entry, some clinics use calcium ionophore, a chemical that mimics the calcium signal that normally triggers the egg to begin developing. A meta-analysis of fourteen studies found that artificial oocyte activation with calcium ionophore increased clinical pregnancy rates more than threefold and also improved fertilization, cleavage, blastocyst formation, and implantation rates.¹⁸ Follow-up research on the safety of this approach, including chromosomal testing of blastocysts produced after calcium ionophore use, has been reassuring, with no significant effect on the rate of chromosomal abnormalities or on birth outcomes.¹⁹

Calcium ionophore is not appropriate for every case. It targets a specific problem: eggs that are not activating properly after ICSI. If the embryos fertilized normally but arrested later in development, the issue lies elsewhere. Still, for patients with repeated fertilization failure or very early arrest, it is one of the few lab-level interventions with strong evidence behind it.

Early Clues From Time-Lapse Monitoring

Time-lapse incubators, which photograph embryos every few minutes without removing them from controlled conditions, have given embryologists a much more detailed view of how early development unfolds. Certain timing patterns and behaviors during the first couple of days after fertilization turn out to be strong predictors of whether an embryo will reach blastocyst. Embryos whose first cell division events are delayed beyond specific time windows show markedly lower blastocyst formation rates. Abnormal behaviors, including fragmentation of more than half the embryo’s volume, cells dividing directly from one to three (skipping two), cells reversing their division, and prolonged pauses in development, are all associated with failure to form a blastocyst.²⁰

For patients who experienced total arrest, time-lapse data from the failed cycle, if available, can provide useful information for the clinical team. If the embryos showed very early abnormal cleavage patterns, that may point more toward an egg or sperm quality issue. If they developed normally through the cleavage stage and then arrested around day three or four, the genome activation hurdle becomes a more likely suspect. This kind of retrospective analysis does not change the outcome of the failed cycle, but it helps refine the strategy for the next one.

What the Odds Look Like for a Second Cycle

Perhaps the most pressing question after total embryo arrest is whether it is worth trying again. A study tracking patients whose first IVF cycle produced no embryos suitable for transfer found that the cumulative live birth rate across subsequent attempts was 36 percent per patient. Nearly all of those births, 99 percent, occurred within the first three additional attempts. Beyond six cycles with no transfer-quality embryos, no pregnancies were recorded.²¹

Those numbers are worth sitting with. A 36 percent cumulative live birth rate is lower than the general IVF population, but it is not negligible. It means that for roughly one in three patients who experience total failure the first time, persistence pays off. But it also means that most of the success comes in the next couple of tries, and repeated cycles without any improvement in embryo development becomes a strong signal that something more fundamental is at play.

The same matched analysis that found protocol changes unhelpful also quantified how much a prior episode of total arrest affects subsequent cycles. Patients with a history of complete embryo developmental arrest had a blastulation rate of about 33 percent in their next cycle, compared to 47 percent for matched controls without that history. They were also nearly twice as likely to experience another cycle with zero blastocysts.¹⁷ These findings suggest that total arrest is not just bad luck in many cases; it reflects an underlying tendency that persists across cycles, even if the severity can vary from one attempt to the next.

When Multiple Factors Stack Up

In practice, total embryo arrest rarely comes down to a single clean explanation. Mild sperm DNA fragmentation paired with borderline egg quality might produce embryos that could have survived if either factor were better. Slightly suboptimal lab conditions on top of age-related mitochondrial decline might push a marginal embryo over the edge. The genome activation step requires contributions from both the egg’s stored resources and the newly formed embryo genome, so anything affecting either side compounds the risk.

The review literature on early embryonic arrest emphasizes this point: maternal factors like follicular development problems and specific gene mutations combine with paternal factors like chromosomal variations and sperm gene mutations to create cumulative risk.¹³ This is frustrating because it means there may not be one fixable problem. But it also means that even small improvements on multiple fronts, better sperm selection, optimized culture conditions, slightly different timing of egg retrieval, can sometimes collectively tip the balance enough to get one or two embryos through to blastocyst in a subsequent cycle.

For patients working through this experience, the most productive conversation with a fertility specialist focuses not just on what to do differently next time, but on which of the known contributors can actually be investigated and addressed. Sperm DNA fragmentation testing, genetic panel testing after repeated failures, review of lab culture protocols, and consideration of interventions like calcium ionophore for appropriate cases are all concrete steps that move the diagnostic picture forward rather than just hoping the next cycle goes differently by chance.